For babies born by Caesarean section, can a simple swab reduce rates of obesity, asthma and allergies?

newborn grasping adult finger

Inova clinical trial investigates outcomes of exposing newborns to mother’s microbes While Caesarean section (CS) delivery can be lifesaving for both new mothers and their babies, children born by CS have an approximately 50 percent increased risk of childhood obesity, along with asthma and allergies. There is a marked difference between the microbiomes, the community…

Read More

Inova cardiac researchers publish JAMA article on use of intensive lipid-lowering drugs

The question over who should use cholesterol reducing medication is a hotly debated topic among physicians. Researchers at Inova just published an analysis in the current edition of the Journal of the American Medical Association (JAMA) providing foundational findings that will help change the understanding of when and how to use intensive lipid-lowering therapy to…

Read More

The Society for Women’s Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors

inova logo

Washington, DC —The Society for Women’s Health Research (SWHR) announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women…

Read More

The GALILEO Trial: Inova Researchers Study New Drug Therapy for Heart Patients

Matthew W. Sherwood, MD, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Heart and Vascular Institute. Read Dr. Sherwood’s profile. Starting in March, we began enrolling patients in a first-of-its-kind study to compare drug therapies for patients who have had transcatheter aortic valve replacement, or TAVR. As…

Read More

From Research to Results: Advances in Genitourinary Cancer Treatment  

Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile.  This February, I’ll be traveling to…

Read More

Children’s National and Inova Announce Three-Year, $2.8 million Research and Education Collaboration

inova logo

Partnership to yield major, nationally competitive research and academic program in maternal, fetal and neonatal medicine WASHINGTON – (January 12, 2017) – Children’s National Health System and Inova this week announced a new three-year, $2.8 million research and education collaboration in maternal, fetal and neonatal medicine that aims to leverage the strengths of both health…

Read More

Inova Translational Medicine Receives $9.5M Award from NIH to Study Environmental Influences on Child Health

inova logo

Grant is part of a larger consortium award led by the Icahn School of Medicine at Mount Sinai Medical Center Falls Church, VA – October 3, 2016 – Inova Health System announced that the Inova Translational Medicine Institute (ITMI) has been awarded a $9.5M grant from the National Institutes of Health (NIH) to study environmental…

Read More